论文部分内容阅读
目前,透析治疗仍然是中末期肾病的主要治疗手段,但透析过程中发生心血管疾病的几率也非常高,并成为最重要的死亡原因。透析病人心血管疾病的病因是多因素的,其中脂质代谢异常尤为重要。在高血脂的治疗中,他汀类药物与贝特类药物起着重要作用。
At present, dialysis treatment is still the main treatment of end stage renal disease, but the risk of cardiovascular disease during dialysis is also very high, and become the most important cause of death. The cause of cardiovascular disease in dialysis patients is multifactorial, and lipid metabolism disorders are particularly important. Statins and fibrates play an important role in the treatment of hyperlipidemia.